Surgical technique for minimal invasiveness in living donor liver surgery: Knack & Pitfalls
Yuzo Umeda(Okayama University), Fujiwara Toshiyoshi, Daisuke Nobuoka(Fukuyama City Hospital), Kosei Takagi(Okayama Shoka University), Kuise Takashi, Fuji Tomokazu, Nobuyuki Watanabe(Okayama University), Takahito Yagi(Okayama University), Susumu Shinoura(Okayama University), Ryuichi Yoshida(Okayama University)
日本消化器外科学会雑誌(Web)
January 1, 2016
Cited by 0
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
Risk factors for major morbidity after liver resection for hepatocellular carcinoma
|British journal of surgery|2012|104
Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma
|World Journal of Surgery|2017|95
Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria
|Transplant International|2013|92